Evidence map›Paper›PMID 35146217›Full record

ArticleAdvances in radiation oncology

Quality Indicators in Palliative Radiation Oncology: Development and Pilot Testing.

Tetsuo Saito, Naoto Shikama, Takeo Takahashi, Misako Miwa, Kazunari Miyazawa, Hitoshi Wada, Naoki Nakamura, Atsunori Yorozu, Hisayasu Nagakura, Mitsunori Miyashita

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 10 institutions in 1 country.

Tetsuo SaitoDepartment of Radiation Oncology, Arao Municipal Hospital, Kumamoto, Japan.
Naoto ShikamaDepartment of Radiology, Juntendo University School of Medicine, Tokyo, Japan.
Takeo TakahashiDepartment of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Misako MiwaDepartment of Radiation Oncology, Sendai Kousei Hospital, Miyagi, Japan.
Kazunari MiyazawaDepartment of Radiology, Showa General Hospital, Tokyo, Japan.
Hitoshi WadaDepartment of Radiation Oncology, Southern TOHOKU Proton Therapy Center, Fukushima.
Naoki NakamuraDepartment of Radiology, St. Marianna University School of Medicine, Kanagawa, Japan.
Atsunori YorozuDepartment of Radiation Oncology, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan.
Hisayasu NagakuraDepartment of Radiology, KKR Sapporo Medical Center, Sapporo, Japan.
Mitsunori MiyashitaDepartment of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Juntendo University · JPKumamoto City Hospital · JPNTT Medical Center · JPSendai Kousei Hospital · JPShowa General Hospital · JPSocial Insurance Saitama Chuo Hospital · JPSouthern Tohoku General Hospital · JPSt. Marianna University School of Medicine · JPTohoku University · JPTokyo Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA quality indicator (QI) is a valuable tool to evaluate the quality of health care systems. In palliative radiation oncology, only a few related QIs have been developed to date. In this study, we sought to develop and pilot test QIs that assess the quality of care in palliative radiation therapy. METHODS AND MATERIALS: A modified Delphi method was used to establish consensus with an expert panel. The panel consisted of 8 radiation oncologists who have expertise in palliative radiation oncology and 1 expert on Delphi methodology. Online panel meetings and e-mail surveys were conducted to develop QIs on palliative radiation therapy for bone and brain metastases. Feasibility of measurement was assessed though pilot surveys that were conducted by radiation oncologists at 5 facilities.

resultsAfter 3 online meetings and 2 e-mail surveys, we developed 4 QIs on bone metastases and 3 QIs on brain metastases. Two email surveys and 2 pilot surveys confirmed the validity of QIs and the feasibility of measurement, respectively.

conclusionsWe developed valid and feasible QIs on palliative radiation therapy for bone and brain metastases. Our work may contribute to reduce the evidence-practice gaps in palliative radiation oncology.

Identifiers

PMID35146217
PMCPMC8818916
OpenAlexW3217425892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.